Zhen Cheng Selected Research

Zhen Cheng Research Topics

Disease

153	Neoplasms (Cancer) 11/2022 - 02/2002
20	Melanoma (Melanoma, Malignant) 01/2021 - 02/2002
10	Glioblastoma (Glioblastoma Multiforme) 11/2022 - 11/2005
9	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2007
9	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 02/2012
8	Glioma (Gliomas) 01/2022 - 10/2005
8	Inflammation (Inflammations) 01/2021 - 01/2012
7	Carcinogenesis 01/2022 - 01/2011
7	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 07/2012
6	Neoplasm Metastasis (Metastasis) 01/2021 - 10/2005
5	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 04/2014
5	Carcinoma (Carcinomatosis) 10/2019 - 06/2012
4	Liver Neoplasms (Liver Cancer) 01/2022 - 03/2014
4	Glomerulonephritis 01/2021 - 09/2016
4	Atherosclerotic Plaque (Atheroma) 01/2020 - 01/2012
4	Lung Neoplasms (Lung Cancer) 08/2019 - 02/2012
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022 - 01/2018
3	Osteoporosis 12/2021 - 01/2018
3	IGA Glomerulonephritis (IGA Nephropathy) 05/2020 - 12/2017
3	Rupture 01/2020 - 06/2015
3	Disease Progression 01/2020 - 01/2016
3	Myocardial Infarction 01/2020 - 01/2014
3	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2019 - 12/2016
3	Stroke (Strokes) 01/2018 - 06/2015
3	Atherosclerosis 10/2016 - 01/2012
2	Amyloidosis 11/2022 - 01/2021
2	Brain Neoplasms (Brain Tumor) 11/2022 - 02/2015
2	Hyperthermia 07/2022 - 02/2022

Drug/Important Bio-Agent (IBA)

45	Peptides (Polypeptides)IBA 06/2021 - 02/2002
28	IntegrinsIBA 10/2019 - 10/2005
23	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2008
20	Molecular Probes (Molecular Probe)IBA 01/2021 - 05/2005
19	ErbB Receptors (EGF Receptor)IBA 01/2021 - 05/2008
15	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2020 - 02/2002
14	Pharmaceutical PreparationsIBA 01/2022 - 05/2006
13	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2009
13	Radioisotopes (Radionuclides)IBA 01/2021 - 02/2002
11	Melanins (Melanin)IBA 01/2021 - 10/2009
10	Coloring Agents (Dyes)IBA 09/2022 - 05/2010
10	Cystine-Knot MiniproteinsIBA 10/2019 - 03/2009
9	arginyl-glycyl-aspartic acidIBA 11/2014 - 10/2005
8	Contrast MediaIBA 06/2020 - 01/2011
8	Cystine (L-Cystine)IBA 10/2019 - 02/2010
6	EnzymesIBA 10/2020 - 06/2011
6	GoldIBA 10/2020 - 04/2013
6	CY5.5 cyanine dyeIBA 01/2020 - 05/2006
6	LigandsIBA 01/2019 - 07/2013
6	Bombesin Receptors (Bombesin Receptor)IBA 01/2018 - 06/2012
6	MetalsIBA 01/2017 - 02/2002
6	Type 1 Melanocortin ReceptorIBA 03/2014 - 05/2007
5	IronIBA 01/2022 - 02/2011
5	Therapeutic UsesIBA 01/2021 - 06/2014
5	AcidsIBA 01/2018 - 03/2009
5	Indicators and Reagents (Reagents)IBA 10/2016 - 10/2005
5	RheniumIBA 12/2010 - 02/2002
5	alpha-MSHIBA 11/2009 - 02/2002
4	Arginine (L-Arginine)FDA Link 10/2020 - 04/2010
4	Monoclonal AntibodiesIBA 01/2020 - 08/2014
4	Biological ProductsIBA 01/2020 - 06/2005
4	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 01/2020 - 09/2011
4	Glucose (Dextrose)FDA LinkGeneric 10/2019 - 05/2006
4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2019 - 04/2016
4	Fluorescent Dyes (Fluorescent Probes)IBA 10/2018 - 11/2005
4	Chelating AgentsIBA 01/2017 - 06/2011
4	PeptidomimeticsIBA 01/2012 - 12/2009
3	Tyrosine Kinase InhibitorsIBA 05/2022 - 01/2018
3	IonsIBA 01/2022 - 09/2015
3	CreatinineIBA 10/2021 - 09/2012
3	Immunoglobulin A (IgA)IBA 01/2021 - 12/2017
3	AntigensIBA 01/2021 - 04/2014
3	CytokinesIBA 01/2020 - 11/2011
3	Human Serum Albumin FDA LinkGeneric 01/2020 - 01/2012
3	AminesIBA 08/2019 - 06/2005
3	Testosterone (Sustanon)FDA Link 01/2019 - 12/2016
3	Urokinase Plasminogen Activator ReceptorsIBA 11/2018 - 07/2013
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 04/2017 - 11/2015
3	CathepsinsIBA 10/2016 - 01/2011
3	Cysteine (L-Cysteine)FDA Link 10/2016 - 01/2011
3	Tumor Biomarkers (Tumor Markers)IBA 06/2016 - 05/2008
3	Aspartic Acid (Aspartate)FDA Link 01/2016 - 04/2010
3	Firefly LuciferasesIBA 06/2014 - 05/2007
3	Thymidine KinaseIBA 06/2014 - 01/2006
3	BombesinIBA 12/2013 - 06/2012
3	Agouti-Related ProteinIBA 02/2013 - 02/2010
3	acetyl0Nle(4)-Asp(5)-Phe(7)- alpha-MSH (4-11)IBA 11/2012 - 05/2007
3	Integrin alphaVbeta3IBA 02/2010 - 10/2005

Therapy/Procedure

58	Therapeutics 02/2022 - 10/2005
13	Precision Medicine 11/2022 - 05/2014
9	Quantum Dots (Quantum Dot) 09/2018 - 09/2008
8	Computer-Assisted Surgery (Image Guided Surgery) 11/2022 - 05/2017
8	Drug Therapy (Chemotherapy) 10/2020 - 02/2012
6	Photothermal Therapy 02/2022 - 03/2014
6	Immunotherapy 01/2022 - 05/2016
5	Lasers (Laser) 01/2018 - 11/2012
4	Transplantation 10/2021 - 12/2006
4	Photochemotherapy (Photodynamic Therapy) 04/2017 - 03/2014
3	Ligation 01/2020 - 06/2015
3	Radiotherapy 01/2018 - 02/2002
3	Intravenous Injections 10/2016 - 01/2006
3	Intravenous Administration 03/2014 - 01/2006